<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01101867</url>
  </required_header>
  <id_info>
    <org_study_id>Novo Nordisk xxxx</org_study_id>
    <nct_id>NCT01101867</nct_id>
  </id_info>
  <brief_title>Prandial Insulin Dosing in Hospitalized Patients</brief_title>
  <acronym>ICHO</acronym>
  <official_title>Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kathleen Dungan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether mealtime insulin results in better control
      of blood sugar than a fixed meal dose in hospitalized patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether mealtime insulin, dosed to match the intake
      of carbohydrates (starches or sugars) results in better control of blood sugar than a fixed
      meal dose in hospitalized patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Glucose</measure>
    <time_frame>day 3</time_frame>
    <description>Mean glucose was calculated per participant from the average of glucose values over the 7-point (pre- and post-breakfast, lunch, dinner, and bed) glucose profile at day 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial Glucose</measure>
    <time_frame>day 3</time_frame>
    <description>Mean postprandial glucose was calculated per participant from the average of glucose values (post-breakfast, lunch, dinner) at day 3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia</measure>
    <time_frame>72 hour</time_frame>
    <description>Number of patients with any hypoglycemic event (&lt;70 mg/dl or &lt;40 mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Glucose</measure>
    <time_frame>72 hour</time_frame>
    <description>Change in mean glucose from day 1 to day 3, measured as difference in mean glucose day 3 minus mean glucose day 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Satisfaction</measure>
    <time_frame>day 3</time_frame>
    <description>treatment satisfaction questionnaire validated in-hospital, 19 item questionnaire using 0-6 point likert scale, for minimum zero to maximum of 102 points (with 102 indicating best satisfaction). Items are summed to find the total score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1,5-anhydroglucitol Change</measure>
    <time_frame>day 1 to day 3</time_frame>
    <description>change in short-term measure of glycemia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Diabetes</condition>
  <condition>Admitting Hospital</condition>
  <condition>Non-critically Ill</condition>
  <arm_group>
    <arm_group_label>Aspart flexible dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>aspart dose determined based upon carbohydrate intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspart fixed dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspart fixed dose</intervention_name>
    <description>fixed dose</description>
    <arm_group_label>Aspart fixed dose</arm_group_label>
    <other_name>Novolog</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspart flexible dose</intervention_name>
    <description>dose based upon carbohydrate intake and total daily requirements</description>
    <arm_group_label>Aspart flexible dose</arm_group_label>
    <other_name>Novolog</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  general medical or minor surgical hospitalized patients

          -  type 2 diabetes

          -  blood glucose 150-400 on at least 2 occasions within 24 hours or requiring at least 20
             units of insulin/day in the 24 hours prior to enrollment

        Exclusion Criteria:

          -  â€¢ Major surgery, occurring within the previous 2 weeks or planned within 72 hours of
             study entry, including cardiothoracic, neurosurgical, and open intra-abdominal
             procedures (in particular, any surgery lasting over 2 hours).

               -  Patients receiving glucocorticoids, total parental nutrition (TPN), or tube
                  feeds.

               -  Pregnancy (glucose targets differ in pregnancy). Premenopausal women not on
                  pharmacologic contraceptives, inrauterine device (IUD), or surgical menopause
                  will undergo pregnancy testing.

               -  Patients currently on IV insulin (must wait to enroll) or with planned surgical
                  procedures in the next 72 hours for whom intravenous insulin will be likely

               -  Prolonged (&gt;24 hour) strict nil per os (NPO-nothing by mouth) status (eg. small
                  bowl obstruction). Liquid or modified consistency diets are acceptable.

               -  Patients for whom expected length of stay will be less than 48 hours

               -  Patients using subcutaneous insulin pumps

               -  Diabetic ketoacidosis

               -  End-stage renal disease on dialysis

               -  End-stage liver disease with cirrhosis

               -  Mental conditions precluding informed consent

               -  Potentially sensitive admissions: prisoners, HIV, suicidality

               -  Unable to give consent in English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathleen M Dungan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2010</study_first_submitted>
  <study_first_submitted_qc>April 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2010</study_first_posted>
  <results_first_submitted>April 9, 2013</results_first_submitted>
  <results_first_submitted_qc>May 28, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 2, 2013</results_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Kathleen Dungan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>glucose</keyword>
  <keyword>hospital</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin degludec, insulin aspart drug combination</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Aspart</mesh_term>
    <mesh_term>Insulin, Long-Acting</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Flexible Dose</title>
          <description>Insulin Aspart dose is determined based upon carbohydrate intake and is administered immediately post-meal. Prandial insulin was based upon the formula: CIR=400/TDD where CIR refers to the carbohydrate-to-insulin ratio and TDD refers to the total daily calculated dose of insulin (based upon total daily insulin dose or upon weight, depending upon whether a patient is insulin naive or not, respectively).</description>
        </group>
        <group group_id="P2">
          <title>Fixed Dose</title>
          <description>Fixed meal dose of Insulin Aspart (based upon total daily insulin dose or upon weight, depending upon whether a patient is insulin naive or not, respectively). Half of the TDD was divided into three equal fixed doses given immediately after each meal.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Flexible Dose</title>
          <description>aspart dose determined based upon carbohydrate intake.</description>
        </group>
        <group group_id="B2">
          <title>Fixed Dose</title>
          <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="63"/>
            <count group_id="B2" value="63"/>
            <count group_id="B3" value="126"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57" spread="10"/>
                    <measurement group_id="B2" value="56" spread="12"/>
                    <measurement group_id="B3" value="57" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Glucose</title>
        <description>Mean glucose was calculated per participant from the average of glucose values over the 7-point (pre- and post-breakfast, lunch, dinner, and bed) glucose profile at day 3</description>
        <time_frame>day 3</time_frame>
        <population>Data were only available in 79 subjects on day 3 due to hospital discharge or NPO status.</population>
        <group_list>
          <group group_id="O1">
            <title>Flexible Dose</title>
            <description>aspart dose determined based upon carbohydrate intake.</description>
          </group>
          <group group_id="O2">
            <title>Fixed Dose</title>
            <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Glucose</title>
          <description>Mean glucose was calculated per participant from the average of glucose values over the 7-point (pre- and post-breakfast, lunch, dinner, and bed) glucose profile at day 3</description>
          <population>Data were only available in 79 subjects on day 3 due to hospital discharge or NPO status.</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="158" spread="47"/>
                    <measurement group_id="O2" value="171" spread="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postprandial Glucose</title>
        <description>Mean postprandial glucose was calculated per participant from the average of glucose values (post-breakfast, lunch, dinner) at day 3.</description>
        <time_frame>day 3</time_frame>
        <population>Data were only available in 79 subjects on day 3 due to hospital discharge or NPO status.</population>
        <group_list>
          <group group_id="O1">
            <title>Flexible Dose</title>
            <description>aspart dose determined based upon carbohydrate intake.</description>
          </group>
          <group group_id="O2">
            <title>Fixed Dose</title>
            <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)</description>
          </group>
        </group_list>
        <measure>
          <title>Postprandial Glucose</title>
          <description>Mean postprandial glucose was calculated per participant from the average of glucose values (post-breakfast, lunch, dinner) at day 3.</description>
          <population>Data were only available in 79 subjects on day 3 due to hospital discharge or NPO status.</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="175" spread="51"/>
                    <measurement group_id="O2" value="203" spread="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hypoglycemia</title>
        <description>Number of patients with any hypoglycemic event (&lt;70 mg/dl or &lt;40 mg/dl)</description>
        <time_frame>72 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flexible Dose</title>
            <description>aspart dose determined based upon carbohydrate intake.</description>
          </group>
          <group group_id="O2">
            <title>Fixed Dose</title>
            <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)</description>
          </group>
        </group_list>
        <measure>
          <title>Hypoglycemia</title>
          <description>Number of patients with any hypoglycemic event (&lt;70 mg/dl or &lt;40 mg/dl)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Glucose</title>
        <description>Change in mean glucose from day 1 to day 3, measured as difference in mean glucose day 3 minus mean glucose day 1.</description>
        <time_frame>72 hour</time_frame>
        <population>intention to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Aspart Flexible Dose</title>
            <description>aspart dose determined based upon carbohydrate intake.
Aspart flexible dose: dose based upon carbohydrate intake and total daily requirements</description>
          </group>
          <group group_id="O2">
            <title>Aspart Fixed Dose</title>
            <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)
Aspart fixed dose: fixed dose</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glucose</title>
          <description>Change in mean glucose from day 1 to day 3, measured as difference in mean glucose day 3 minus mean glucose day 1.</description>
          <population>intention to treat population</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="35"/>
                    <measurement group_id="O2" value="-8.1" spread="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Satisfaction</title>
        <description>treatment satisfaction questionnaire validated in-hospital, 19 item questionnaire using 0-6 point likert scale, for minimum zero to maximum of 102 points (with 102 indicating best satisfaction). Items are summed to find the total score.</description>
        <time_frame>day 3</time_frame>
        <population>all participants who completed the survey</population>
        <group_list>
          <group group_id="O1">
            <title>Flexible Dose</title>
            <description>Insulin Aspart dose is determined based upon carbohydrate intake and is administered immediately post-meal. Prandial insulin was based upon the formula: CIR=400/TDD where CIR refers to the carbohydrate-to-insulin ratio and TDD refers to the total daily calculated dose of insulin (based upon total daily insulin dose or upon weight, depending upon whether a patient is insulin naive or not, respectively).</description>
          </group>
          <group group_id="O2">
            <title>Fixed Dose</title>
            <description>Fixed meal dose of Insulin Aspart (based upon total daily insulin dose or upon weight, depending upon whether a patient is insulin naive or not, respectively). Half of the TDD was divided into three equal fixed doses given immediately after each meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Satisfaction</title>
          <description>treatment satisfaction questionnaire validated in-hospital, 19 item questionnaire using 0-6 point likert scale, for minimum zero to maximum of 102 points (with 102 indicating best satisfaction). Items are summed to find the total score.</description>
          <population>all participants who completed the survey</population>
          <units>points on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" spread="14"/>
                    <measurement group_id="O2" value="68" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1,5-anhydroglucitol Change</title>
        <description>change in short-term measure of glycemia</description>
        <time_frame>day 1 to day 3</time_frame>
        <population>subjects with complete data</population>
        <group_list>
          <group group_id="O1">
            <title>Flexible Dose</title>
            <description>Insulin Aspart dose is determined based upon carbohydrate intake and is administered immediately post-meal. Prandial insulin was based upon the formula: CIR=400/TDD where CIR refers to the carbohydrate-to-insulin ratio and TDD refers to the total daily calculated dose of insulin (based upon total daily insulin dose or upon weight, depending upon whether a patient is insulin naive or not, respectively).</description>
          </group>
          <group group_id="O2">
            <title>Fixed Dose</title>
            <description>Fixed meal dose of Insulin Aspart (based upon total daily insulin dose or upon weight, depending upon whether a patient is insulin naive or not, respectively). Half of the TDD was divided into three equal fixed doses given immediately after each meal.</description>
          </group>
        </group_list>
        <measure>
          <title>1,5-anhydroglucitol Change</title>
          <description>change in short-term measure of glycemia</description>
          <population>subjects with complete data</population>
          <units>mcg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="2.76"/>
                    <measurement group_id="O2" value="0.73" spread="3.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>72 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Flexible Dose</title>
          <description>aspart dose determined based upon carbohydrate intake.</description>
        </group>
        <group group_id="E2">
          <title>Fixed Dose</title>
          <description>fixed meal dose of aspart (based upon weight or total daily insulin dose)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycemia (BG &lt;70 mg/dl)</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Miscalculation of meal doses, mistimed doses, lack of complete documentation of carbohydrate intake, and dosing conducted by an experienced clinician may have contributed to the findings.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Kathleen Dungan</name_or_title>
      <organization>The Ohio State University</organization>
      <phone>614-685-3333</phone>
      <email>kathleen.dungan@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

